Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL

AIMS: Data from the EDITION 3 randomized study and the Clinformatics claims database were analysed to determine whether insulin glargine 300 U/mL (Gla‐300) could provide insulin‐naive patients with type 2 diabetes (T2D) on oral antidiabetes drugs (OADs) with reductions in prior OAD therapy without c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dailey, George, Reid, Timothy, White, John, Chao, Jason, Zhou, Fang L., Paranjape, Sachin, Berhanu, Paulos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354822/
https://www.ncbi.nlm.nih.gov/pubmed/30815563
http://dx.doi.org/10.1002/edm2.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354822/
https://www.ncbi.nlm.nih.gov/pubmed/30815563
http://dx.doi.org/10.1002/edm2.35

Ejemplares similares